Enteroendocrine cells (EECs) control a wide range of physiological processes linked to metabolism 1 . We show that EEC hormones are differentially expressed between crypts (for example, Glp1) and villi (for example, secretin). As demonstrated by single-cell mRNA sequencing using murine Lgr5 + cell-derived organoids, BMP4 signals alter the hormone expression profiles of individual EECs to resemble those found in the villus. Accordingly, BMP4 induces hormone switching of EECs migrating up the crypt-villus axis in vivo. Our findings imply that EEC lineages in the small intestine exhibit a more flexible hormone repertoire than previously proposed. We also describe a protocol to generate human EECs in organoids and demonstrate a similar regulation of hormone expression by BMP signalling. These findings establish alternative strategies to target EECs with therapeutically relevant hormone production through BMP modulation.
1
. Other EEC subtypes include gastric inhibitory protein (Gip)-producing K cells, somatostatin (Sst)-producing D cells, cholestocystokinin (Cck)-producing I cells, neurotensin (Nts)-producing N cells and secretin (Sct)-producing S cells 1 . Although this classification suggests well-defined, distinct EEC subtypes, these hormones are often coexpressed, suggesting considerable overlap between lineages 3, 4 . As is the case for all cell types of the intestinal epithelium, the short-lived EECs are constitutively produced by Lgr5 + crypt stem cells 5 . Lgr5 stem cells can be cultured to generate epithelial organoids that faithfully recapitulate gut epithelial biology 6 . Single-cell messenger RNA sequencing (scRNA-seq) has shown that a complete set of EECs subtypes is produced in these mini-guts, including some that had previously gone unnoticed in intact gut 7, 8 . However, extrinsic factors that control EEC subtype identity have remained largely unknown.
Previous work has suggested that EECs expressing Tac1 and Glp1 are restricted to crypts, whereas Sct-, Pyy-and Nts-producing EECs are enriched in villi 9, 10 . In agreement with these studies, we found that ileal L cells co-express Glp1 and Pyy in the crypt, but mostly lack Glp1 in the villus (Fig. 1a-c and Supplementary Fig.  1a ). Serotonin-producing ECs occurred along the length of the crypt-villus axis, but selectively co-expressed Tac1 in the crypt and Sct in the villus (Fig. 1d ,e and Supplementary Fig. 1a ). To address whether hormone switching occurs during migration of EECs along the crypt-villus axis, we analysed intestines from Tac1 iresCre /Rosa tdTomato mice, an allele that faithfully labels all Tac1 + / Serotonin + cells in the crypt (Fig. 1f ) 11 . In adult intestines, almost all serotonin + cells were marked by tdTomato (Fig. 1g) . Importantly, > 55% of Sct + cells on villi were also traced, while being negative for Tac1 (Fig. 1f,g and Supplementary Fig. 1b ). The rarity of tdTomato + cells that were negative for serotonin suggests that ECs do not lose serotonin during their lifetime to become single Sct + as previously suggested 9, 12 . Serotonin-negative Sct + cells not traced by Tac1 must thus be part of another EEC lineage. EECs producing other hormones, including Cck, Gip and Sst, were only rarely derived from Tac1 + progenitors ( Fig. 1g and Supplementary Fig. 1b ). These data imply lineage relationships between crypt and villus EECs; that is, that Tac1 − /Sct + ECs on villi derive from Tac1 + crypt ECs. This, in turn, suggests that local niche signals can induce shifts in hormone expression.
Multiple signalling gradients exist along the crypt-villus axis; for example, Wnt levels are high at the crypt base, while BMP is highest at the villus tips 13, 14 . In murine intestinal organoids, EECs are induced through inhibition of the Wnt, MAPK and Notch signalling pathways, in the presence of the BMP inhibitor Noggin 8 . We used this differentiation system as a starting point to modulate selected signalling pathways 8 , while monitoring Sct and Gcg as a proxy of the villus-and crypt-hormone signatures, respectively. Strikingly, we observed that all ECs in this culture co-expressed serotonin and Tac1, while Sct was absent (Fig. 2a) . This suggests that niche signals acting on EECs are dominant over a default, temporal differentiation process. Manipulation of the Wnt, TGF-β and Hedgehog pathways did either reduce both Gcg and Sct transcripts, or had no significant effect on any assessed hormone ( Supplementary Fig. 2a ). We replaced Noggin by BMP4 in this EEC differentiation cocktail ('EEC BMP high ' medium), generating cells immunoreactive for Sct, as well as ECs lacking Tac1 (Fig. 2a,b ). Glp1
+ cell numbers and total levels of secreted Glp1 were greatly diminished (Fig. 2a-c and Supplementary Fig. 2b ). We next performed bulk RNA-seq on duodenal and ileal organoids stimulated with EEC BMP high or EEC BMP low media (Fig. 2d) , and validated the expression of selected genes by quantitative PCR (PCR; Fig. 2e ). EEC markers that are homogeneously distributed on crypts and villi (Chga, Tph1 (enzyme catalysing serotonin production), Cck and duodenal Gip) are only mildly affected by BMP activation (Fig. 2d,e) . We did observe an increase in Sct and a minor upregulation of Pyy and Nts (Fig. 2d,e) , which are expressed at the highest levels in the villus 10 . Sct is enriched
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NATuRE CELL BiOLOGy in the proximal part of the SI 1 , but we observe that our EEC differentiation protocol generates Sct + cells equally well in the proximal and distal small intestinal organoids. Trpa1, an irritant receptor enriched in EECs of the intestinal crypt 15 , decreased with BMP activation (Fig. 2d) . BMP4-mediated changes in hormone expression could be overridden by the addition of the BMPR1a inhibitor LDN193189, confirming involvement of the BMPR1/2 axis ( Supplementary Fig. 2c,d ).
To address whether BMP signalling can switch hormone expression in individual mature EECs rather than selectively depleting subtypes of EECs, we followed the fate of Gcg-or Tac1-expressing cells using cultures derived from Gcg Venus and Tac1 iresCre /Rosa26 tdTomato mice 11, 16 . Live-cell imaging of Gcg Venus organoids demonstrated that BMP activation induced a decrease in Venus levels, suggesting downregulation of Gcg ( Supplementary Fig. 2e,f) . We did not observe BMP-induced apoptosis of Venus + or tdTomato + cells (Supplementary Fig. 2g ).
Changes in hormone expression in individual EECs might be caused by dynamics in transcriptional networks, and accompanied by the production of other sensory receptors. To identify dynamics at a single-cell level, we performed scRNA-seq of traced Tac1-, Gcg-or Gip-expressing murine cells 16 . Gip + K cells exist both in crypts and villi and were isolated from organoids derived from a Gip Cre /Rosa26 tdRFP mouse 17 . Guided by their regional in vivo abundance, we isolated organoids from the proximal small intestine of Gip, from the distal small intestine of Gcg and from the whole small intestine of Tac1 reporter mice. Organoids were treated with a MEK inhibitor to limit new EEC generation and either exposed to Noggin (control) or BMP4 for 24 or 96 h (Fig. 3a) . Next, EECs derived from the reporters/treatments were sorted for the reporter fluorescence and scRNA-seq was performed using SORTseq 18 , an automated version of CELseq2 ( Fig. 3a and Supplementary  Fig. 3a ) 19 . K-medoids clustering by the RaceID2 algorithm 20 showed that Tac1-, Gcg-and Gip-traced cells, classically defined as ECs, L-and K-cells, respectively, clustered according to their cell type and mostly independently of the treatment in a t-distributed stochastic neighbour embedding (t-SNE) space (Fig. 3b,c) . We identified Alpi + enterocytes and Muc2 + goblet cells derived from the Gcg Venus reporter that displayed the lowest Venus fluorescence intensity ( Supplementary Fig. 3b ). We also detected a cluster of unknown identity with expression of the vomeronasal receptor Vmn2r55, which was identified previously 7 . BMP-stimulated ECs The number of positive cells for each hormone was quantified and is displayed per millimetre of organoid epithelium. The percentages of serotonin + cells that co-express Tac1 are presented (right). The sample size represents two biologically independent experiments, in which at least three organoids were quantified per replicate and staining. Mean values per treatment are shown and error bars depict s.d. and were derived from n = 12 organoids for Sct, and n = 6 organoids for other hormones in BMP low and BMP high conditions. P values were calculated from these same n numbers using a two-sided t-test. c, Overlay of bright-field and Venus images of organoids derived from Gcg Venus mice after a four-day treatment with a BMP low or BMP high EEC differentiation cocktail. BMP activation represses expression of Gcg, without inducing morphological alterations. The experiment was repeated independently ten times. d, Volcano plots showing results from RNA-seq of organoids stimulated for four days with BMP low or BMP high EEC differentiation cocktails, from proximal (left) and distal (right) small intestinal organoids. Gene expression fold change (log 2 ) of BMP high versus BMP low is shown on the x axis and significance on the y axis. Each grey dot represents a gene, and dots representing relevant genes are highlighted in different colours, according to their function. Sample size represents two biologically independent experiments, and P-adjusted values were calculated with a Wald test using the DESeq2 package. e, qPCR analysis of selected hormones from d. Expression levels are shown relative to control organoids in ENR medium. The experiment was performed in n = 2 biologically independent experiments, and the mean expression is depicted. Scale bars, 50 µ m.
NATuRE CELL BiOLOGy displayed a lower Sct expression level compared to L and K cells ( Fig. 3c-e) . Within ECs, expression of Tph1 remained unchanged during BMP treatment, while Tac1 decreased ( Fig. 3c-e) . Cells clustering as classical L cells reduced their Gcg (Glp1) expression, while activating Nts and Pyy transcription following BMP treatment ( Fig. 3d and Supplementary Fig. 3c ). Some Gcg Venus -sorted cells from ileal organoids expressed Gip, combined with low levels of Gcg ( Fig. 3b-d ). These cells clustered together with K cells and could not be induced to express Nts, indicating that these cells represent K cells and not L cells. (Fig. 3d ). L cells and to a lesser extent K cells express Cck independent of treatment ( Fig. 3d) .
Within Gip-traced K cells, we observed a separate population of 
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Sst-producing cells. BMP activation had no effect on Sst expression and caused a mild reduction in Gip expression in these clusters, while activating Sct expression only in Gip + but not in Sst
3d,e and Supplementary Fig. 3c ). Pyy expression could be induced in both Gip + and in Sst + cells, but to a lesser extent than in L cells ( Supplementary Fig. 3c ). We did observe low Cck, Gcg and no Nts expression in K cells, indicating that these represent a separate lineage from ileal L cells (Fig. 3d,e) .
We identified uniquely expressed genes in the various clusters that corresponded to known expression or function along the crypt-to-villus axis in vivo. The irritant receptor Trpa1 (proposed to be involved in serotonin release) is enriched in the crypt 15, 21 . Concordantly, it decreased during BMP treatment within ECs (Fig. 3d,e) . We found the orphan receptor Asic5 to be expressed by Sst + cells (Supplementary Fig. 3d ). This same population also expressed the islet amyloid polypeptide (Iapp) amylin Fig. 3d ), a peptide previously found in pancreatic β cells with a wide range of metabolic effects 22 . The LIM homeobox factor Lmx1a occurs in ECs, as suggested recently 23 . The homeobox protein Hhex-not previously observed in the gut-was expressed by Sst-producing cells (Supplementary Fig. 3d ). Interestingly, Hhex has been described as an essential factor for Sst-producing δ cells in the pancreas 24 . The T-box transcription factor Tbx3 was produced in BMP-activated EECs (Supplementary Fig. 3d) , and enriched in . Finally, we found specific activation of classical BMP target genes in BMP-treated cells, such as Id1, Id2 and Id3, confirming pathway activation ( Supplementary Fig. 3d Fig. 4a ). Strikingly, BMP-activated tdTomato + cells lost Tac1 immunoreactivity, maintained serotonin and gained Sct positivity (Supplementary Fig. 4a ). Glp1 positivity was strongly correlated with Venus expression in Gcg Venus organoids in BMP-untreated conditions, while this correlation is lost in BMP-treated samples (Supplementary Fig. 4a ). Conversely, Venus positivity was increasingly predictive for Sct expression after BMP treatment (Supplementary Fig. 4a ). Pyy peptide positivity remained unchanged irrespective of BMP treatment ( Supplementary Fig. 4a ), in line with the constant peptide levels between the crypt and the villus in vivo Fig. 4b ). Untreated cells retained Tac1 positivity (Supplementary Fig. 4b ). In Gcg Venus -reporter organoids, we observed a similar increase in Sct peptides ( Supplementary Fig. 4b ). Collectively, these data indicate that individual EECs can rewire their peptide hormone profile following activation of BMP signalling.
The number of tdTomato + and Venus + EECs increased significantly over four days when BMP signalling was inhibited versus activated ( Supplementary Fig. 4a ). We found that the first transcription factor expressed by and defining the EEC lineage, neurogenin 3
27
, was inhibited by BMP activation (Supplementary Fig. 4c ). To circumvent a bias that occurs at the bulk population level due to this inhibition of EEC specification, we first generated a large pool of ileal EECs using our differentiation protocol for three days. Next, we switched to BMP high conditions for 24 h ( Supplementary  Fig. 4d ). Increases in Sct, Pyy and Nts expression were more pronounced compared to a continuous BMP inhibition ( Fig. 2 and Supplementary Fig. 4c ). These data imply that initial EEC specification requires BMP low conditions, as exist at the bottom of the crypt. To investigate whether villus-produced BMP controls hormone expression in vivo, we analysed intestines from mice that ectopically express the BMP inhibitor Noggin in the intestinal epithelium (Villin Noggin ) 13 . As expected, we observed an increased expression of Tac1 and Glp1 in the villi of these mice, while Sct was reduced ( Supplementary Fig. 5a-d) . We next tested the feasibility of influencing hormone expression by targeting the BMP gradient with the BMPR1a inhibitor LDN193189
28 . An 80-h oral treatment caused a reduction in Sct + cell numbers. The overall histology of the intestine was unaffected, and the number of Chga + EECs did not change significantly (Fig. 4a,b) , consistent with a previous study 29 . We quantified the numbers of Tac1 + and Glp1 + cells along different segments of the crypt-villus axis, assuming that BMP inhibition would not increase these in the BMP low crypt. BMP inhibition did not cause significant changes in the lowest crypt-villus segment in the number of Tac1 + or Glp1 + EECs (Fig. 4a,c) . However, the increase in cells immunoreactive for Tac1 or Glp1 was very pronounced higher up in the villus (Fig. 4a,c) .
Finally, we pursued the establishment of a differentiation platform for induction of EECs in human intestinal organoids 30 . The best results were obtained with dual inhibition of Notch and MEK signalling (Fig. 5a,b) . This allowed us to generate all subtypes of EECs in organoids derived from either human duodenal or ileal tissue.
ENR-differentiated organoids did not contain EECs but mostly enterocytes, as evidenced by their extensive brush border (Fig. 5a ). In our EEC differentiation protocol, BMP activation induced similar trended alterations in EEC hormone repertoires as it did in murine organoids (Fig. 5c ). NTS and SCT transcripts increased following BMP stimulation, whereas GCG transcripts were reduced (Fig. 5c) . BMP activation had a neutral effect on total CHGA expression, and in contrast to the mouse, PYY was not increased following BMP stimulation (Fig. 5c) . Although cells positive for GLP1 and NTS peptides were observed in control conditions, we observed only NTS single-positive cells in BMP-treated conditions (Fig. 5d) . This implies that BMP control of the expressed EEC hormone repertoire is a generalizable phenomenon. In line with our observations in the murine organoid system 8 , we found that human intestinal organoids maintained their regional identity in terms of representation of EEC subtypes. GCG, NTS and PYY were highly enriched in distal gut organoids, whereas CCK displayed a higher bias towards the duodenum (Fig. 5c) .
Taken together, these data provide two main insights into EEC biology. First, the observations support that BMP controls hormone expression of EECs. EECs that are born in crypts from Lgr5 stem cells encounter increasing levels of BMP signalling when migrating towards the villus tips 31 , and can change their hormone profile during this journey. Second, this insight in combination with the scRNA-seq data proposes a simplification of EEC taxonomy (Fig. 5e) . Previous high-resolution imaging and scRNA-seq data suggested that almost every combination of EEC hormones can occur in individual EECs 32 . Our current data indicate that there might be fewer unrelated differentiation pathways of EECs ('lineages') than previously anticipated and that some of the marker hormones are not hardwired. This implies that EECs uniquely dedicated to the production of Sct or Nts (the so called S or N cells) or Pyy do not exist, and that most EECs initiate expression of Sct when entering the BMP high villus domain. Indeed, we observe that all BMP-activated EECs, except D cells, upregulate Sct to different degrees, while L cells (but not Sst-or serotonin-producing cells) increase Pyy and Nts. Gipexpressing cells can be induced to express lower levels of Pyy, but not Nts. Importantly, we find that Chga is a marker of serotonin-positive cells but not of other EECs, and using it as a generic marker would not allow for identifying EEC regulators such as the BMP pathway.
Pulse-chase labelling using BrdU has indicated that EECs do not necessarily follow the conveyor-belt migration pattern in a constant flow from the bottom of the crypt to the tip of the villus 12, 33 . EECs interact with enteric neurons through synapses, which potentially could alter cellular migration 34, 35 . Subpopulations of EECs can be retained in the crypt for two weeks while maintaining expression of Tac1 or Glp1. Cells that migrate onto the villus are destined to lose Tac1 or Glp1 9, 12, 33 . This ultimately suggests that controlling EEC migration along the crypt-villus axis and the Wnt/BMP gradients would be a way to influence hormone expression patterns.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41556-018-0143-y. 11, 16 , and established as described before 6 . All mice were bred on a C57BL/6 background. All animal procedures and experiments were performed in accordance with national animal welfare laws and were reviewed by the Animal Ethics Committee of the Royal Netherlands Academy of Arts and Sciences (KNAW). All mouse experiments were conducted under a project licence granted by the Central Committee Animal Experimentation (CCD) of the Dutch government and approved by the Hubrecht Institute Animal Welfare Body (IvD), with project licence number AVD8010020151. All rodents are housed in a barrier facility in conventional cages and are changed without using a change station. All personnel entering the barrier must wear protective clothing (including head caps and specials clogs). All animals are received directly from approved vendors (Charles River) or generated in house.
For the BMPR inhibition experiment, LDN193189 (Selleckchem) was dissolved in citric buffer (pH 3-3.1) at 2 mg ml −1
. Twelve-week-old mice (n = 4) were given two oral doses of LDN193189 at 17.5 mg per kilogram of body weight per day. Citric buffer was given to control mice. The total treatment was maintained for 80 h.
Murine and human intestinal organoid culture. The basic culture medium (advanced Dulbecco's modified Eagle's medium/F12 supplemented with penicillin/ streptomycin, 10 mM HEPES, Glutamax, B27 (Life Technologies) and 1 mM Nacetylcysteine (Sigma)) was supplemented with 50 ng ml −1 murine recombinant epidermal growth factor (EGF; Peprotech), R-spondin1 (conditioned medium, 5% final volume) and Noggin (conditioned medium, 5% final volume), called ENR medium. Conditioned media were produced using HEK293T cells stably transfected with HA-mouse Rspo1-Fc (gift from C. Kuo, Stanford University) or after transient transfection with mouse Noggin-Fc expression vector. Advanced Dulbecco's modified Eagle's medium/F12 supplemented with penicillin/ streptomycin, and Glutamax was conditioned for 1 week.
Human duodenal and ileal tissues were obtained from the UMC Utrecht with informed consent of each patient. The study was approved by the UMC Utrecht (Utrecht, the Netherlands) ethical committee and was in accordance with the Declaration of Helsinki and according to Dutch law. This study is compliant with all relevant ethical regulations regarding research involving human participants. Patients were diagnosed with a small or large intestinal cancer and from the resected intestinal segments, a sample was taken from normal mucosa for this study. Human small intestinal cells were isolated, processed and cultured as described previously 30 . Organoids were plated in basement membrane extract (BME; Trevigen). MEK signalling was inhibited using PD0325901 (1 μ M for murine, 100 nM for human organoids; Sigma Aldrich). Wnt secretion was inhibited with IWP-2 (5 μ M; Stemgent) and Notch with DAPT (10 μ M, Sigma Aldrich). BMP signalling was activated by treatment with human recombinant BMP4 (20 ng ml −1 , Peprotech) and withdrawal of Noggin from the culture medium. Hedgehog signalling was inhibited with Vismodegib (10 μ M, Selleckchem). TGF-β signalling was activated using recombinant mouse TGF-β 1 (3 ng ml −1 , R&D Systems, MAB7666TGF beta-1). TGF-β type-1 receptor signalling was inhibited using A83 (500 nM, Tocris). All control organoids were treated with similar concentrations of the compound dissolvent, dimethyl sulfoxide (DMSO) or 0.1% BSA in PBS. During treatments, cells were imaged using an EVOS microscope (Electron Microscopy Sciences).
For the induction of enteroendocrine differentiation in murine organoids, cells were cultured in standard culture conditions (ENR). At 4-7 days after plating in BME, medium was removed and organoids were treated with different regimes. The cocktail for mouse EEC differentiation included: IWP2 (5 μ M; Stemgent), DAPT (10 μ M, Sigma Aldrich) and MEK inhibitor PD0325901 (1 μ M; Sigma Aldrich), while BMP4 (20 ng ml −1 , Peprotech) was added for activation of BMP signalling. In human organoids, differentiation was achieved by withdrawing the p38 MAPK inhibitor SB202190, the TGF-β inhibitor A83, nicotinamide and Wnt-conditioned medium from the culture medium as described previously 30 . Differentiation into EECs was performed by, as well as removing these same factors, additionally treating the medium with DAPT (10 μ M, Sigma Aldrich) and the MEK inhibitor PD0325901 (500 nM; Sigma Aldrich); BMP4 (20 ng ml −1 , Peprotech) was added for activation of BMP signalling. A step-by-step protocol for human EEC differentiation can be found at Nature Protocol Exchange 36 .
Immunostaining. Whole organoids were collected by gently dissolving the BME in ice-cold medium, and subsequently fixed at RT in 4% formalin (Sigma) for at least 6 h. Next, organoids were permeabilized and blocked in PBS containing 0.5% Triton X-100 (Sigma) and 2% normal donkey serum (Jackson ImmunoResearch) for 30 min at room temperature. Organoids were incubated for 2 h at room temperature in blocking buffer containing primary antibodies. Primary antibodies used were goat anti-chromogranin A (1:500; Santa Cruz), goat anti-cholestocystokin (sc-21617,1:100; Santa Cruz), rabbit anti-neurotensin (sc-20806,1:100; Santa Cruz), goat anti-secretin (sc-26630,1:100; Santa Cruz), goat anti-somatostatin (sc-7819, 1:100; Santa Cruz), goat anti-serotonin (ab66047, 1:1,000, Abcam), rabbit anti-gastric inhibitory polypeptide (ab22624-50, 1:500; Abcam), goat anti-GLP1 (sc-7782, 1:100; Santa Cruz), rabbit anti-GLP1 (ab22625, 1:200; Abcam), rabbit anti-peptide YY (ab22663, 1:500; Abcam) and guinea pig anti-substance P (1:200, ab10353; Abcam). Organoids were incubated with the corresponding secondary antibodies Alexa488-, 568-and 647-conjugated antirabbit and anti-goat (1:1,000; Molecular Probes) in blocking buffer containing 4ʹ ,6-diamidino-2-phenylindole (DAPI; 1;1,000, Invitrogen). Sections were embedded in Vectashield (Vector Labs) and imaged using an Sp8 confocal microscope (Leica). Image analysis was performed using ImageJ software. For immunohistochemistry of organoids within the BME ( Supplementary  Fig. 4) , medium was removed from the wells and replaced with 4% formalin for 1 h. Next, organoids were washed with PBS, permeabilized and blocked in PBS containing 0.5% Triton X-100 (Sigma) and 2% normal donkey serum (Jackson ImmunoResearch) for 30 min at room temperature. The wells were incubated for 2 h at room temperature in blocking buffer containing primary antibodies. After washing, secondary antibodies were added for 1 h at room temperature in blocking buffer. Organoids were subsequently imaged within the plate using an Sp8 confocal microscope (Leica).
For immunohistochemistry of mouse intestinal tissue, intestines were first flushed with 4% formaldehyde. Next, intestines were fixed for 6 h at room temperature in 4% formalin. The tissue was either embedded in paraffin or Tissue-Tek O.C.T. for cryosectioning, and stained as described previously 6, 37 . Quantification of the number/location of EECs on intestinal section images was performed in ImageJ software, as well as the intensity of Venus levels in the live-cell imaging experiment in Supplementary Fig. 2e ,f. Analysis of Glp1
+ cell numbers and/or position in Figs. 1a-c and 4-c and Supplementary Fig. 5 was performed in the ileum, and all other hormones were counted along the whole small intestinal tract.
All quantifications were performed on the raw, unprocessed images.
RNA isolation and quantitative PCR.
For qPCR analysis and bulk RNA-seq, RNA was isolated from organoids using the RNAeasy kit (QIAGEN) as instructed in the manufacturer's protocol. PCR analysis was performed using the SYBR Green and Bio-Rad systems as described previously 38 . PCR reactions were performed in duplicate with a standard curve for every primer. Changes in expression were calculated using CFX manager software (Bio-Rad). Primers were designed using the NCBI primer design tool. Primers used in this study are presented in Supplementary Table 1 .
Glp1 and secretin secreted peptide. The supernatant from organoids was collected after 2-h stimulation with forskolin. The Glp1 concentration in the supernatant was measured with a Glp1 EIA Kit (Rab0201, Sigma, detects both full-length and N-terminal cleaved Glp1) using the manufacturer's protocol. The secretin concentration was measured with a Secretin EIA kit (EK-067-04, Phoenix Pharmaceuticals) using the manufacturer's protocol.
Bulk and scRNA-seq. For bulk RNA-seq analysis, organoids stimulated with EEC BMP high or EEC BMP low media for four days were collected and dissociated in RTL buffer (RNeasy Mini kit, Quiagen). Total RNA was isolated accordingly to the manufacturer's instructions (RNeasy Mini kit, Quiagen). Sequencing libraries were prepared on the basis of a modified CELseq2 method 19 . Briefly, 1 ng of RNA was reverse transcribed using the Ambion kit and in vitro transcription was performed using 1 ng of cDNA as a template. The aRNA was then used to prepare sequencing libraries. These resulting DNA libraries were sequenced with sequenced paired-end at 75 bp read-length on the Illumina NextSeq.
For scRNA-seq, organoids were first dissociated into single cells through mechanical disruption, after 15 min of trypsin treatment at 37 °C (TrypLE Express; Life Technologies). Next, cells were immediately sorted using a BD FACS Aria (BD Biosciences). For the single-cell sequencing experiment, cells were sorted as single cells into 384-well plates containing ERCC spike-ins (Agilent), RT primers and dNTP (Promega) as described before. Plates were prepared using Mosquito HTS (TTPlabtech). scRNA-seq libraries were prepared following the SORT-seq protocol 18 , which is based on the CEL-seq2 method 19 . Briefly, cells were first lysed for 5 min at 65 °C, and RT and second-strand mixes were dispensed by the Nanodrop II liquid handling platform (GC Biotech). Single-cell double-stranded cDNAs were pooled together and in vitro transcribed for linear amplification. Illumina sequencing libraries were prepared using the TruSeq small RNA primers (Illumina) and these DNA libraries were sequenced paired-end at 75 bp read length on the Illumina NextSeq.
RNA-seq data analysis. Paired-end reads from Illumina sequencing were aligned to the mouse transcriptome genome by BWA 39 . For RNA-seq bulk data, normalization and differential gene expression analyses were performed using the DESeq2 package 40 and visualized as volcano plots. For scRNA-seq data, read counts were first corrected for UMI barcode by removing duplicate reads that had identical combinations of library, cell-specific and molecular barcodes and were mapped to the same gene. For each cell barcode the number of UMIs for every transcript was counted, and transcript counts were then adjusted to the expected number of molecules based on counts, 256 possible UMIs and Poissonian counting statistics 41 . Samples were then normalized by downsampling to a minimum number of 3,000 transcripts per cell. Cells with fewer transcripts were excluded from the analyses. RaceID2 was used to cluster cells on the basis of the k-medoid method 20 . All data analyses, quantification and data visualization were run on Rstudio. In total, we sequenced 2,880 cells and, after applying a filtering criterion of 3,000 expressed transcripts per cell, 820 cells were retained for further analysis.
Statistics and reproducibility. Two-sided t-tests were performed for all statistical analyses. Precise P values are mentioned in the corresponding figures, and the significance level was set at P < 0.05. In each figure legend, the number of biology replicates is mentioned for the corresponding experiment (n = x). For figures where representative images are shown, the number of times that the experiment has been repeated is mentioned in the legend.
For immunohistochemical experiments, we counted the following number of cells, of organoids or length of intestine: at least 50 cells per hormone and replicate intestine (Fig. 1b-e , n = 4 mice), at least 150 tdTomato + cells per co-staining and replicate intestine (Fig. 1f,g , n = 4 mice), at least 3 organoids per hormone and replicate (Fig. 2a,b , n = 2 biologically independent experiments), 10 organoids per hormone and replicate ( Supplementary Fig. 4a , n = 2 biologically independent experiments), 10 mm of the proximal small intestine for Tac1 (Fig. 4b,c , n = 4 mice per treatment), 30 mm of the distal small intestine for Glp1 (Fig. 4b,c , n = 4 mice per treatment). mice per genotype) and at least 50 cells per hormone and replicate intestine ( Supplementary Fig. 5b,d ; n = 2 mice per genotype).
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article. 
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Bulk and single-cell RNA-seq data that support the findings of this study have been deposited in the Gene Expression Omnibus (GEO) under accession code GSE114988. Source data for Fig. 1c, 1e, 1g , 2b, 2e, 4a, 5b, 5c, 6b and Supplementary Fig. 1a, 2a, 2b , 2d, 3b, 4b, 4c, 5a, 5b and 6 have been provided as Supplementary Table 2 .
